ICAM1 and Sepsis: She reported that applied OMVs from sepsis sepsis-inducing bacteria in contrast to non-sepsis sepsis-inducing bacteria significantly reduced the activity of RNase1 and promoted endothelial cell activation, as indicated by increased IL-8, CXCL10, ICAM-1, and IL-1β expression.